Peter C. Dubsky

Peter C. Dubsky

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.

The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.

Journal: Clinical breast cancer

Published: April 01, 2026

Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial.

Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 23, 2026

Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537].

Corrigendum to "Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study" [The Breast, Volume 83 (2025) 104537].

Journal: Breast (Edinburgh, Scotland)

Published: August 20, 2025

Erratum: De Novo Oligometastatic Breast Cancer.

Erratum: De Novo Oligometastatic Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2025

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.

Journal: NPJ breast cancer

Published: June 02, 2025

The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.

The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.

Journal: The Lancet. Oncology

Published: May 19, 2025

Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study.

Artificial intelligence in breast cancer radiotherapy: Insights from the Toolbox Consortium Delphi study.

Journal: Breast (Edinburgh, Scotland)

Published: May 09, 2025

ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.

ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.

Journal: Breast (Edinburgh, Scotland)

Published: January 29, 2025

Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.

Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 11, 2024

Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis.

Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis.

Journal: Advances in radiation oncology

Published: May 18, 2024

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.

Journal: BMJ open

Published: April 20, 2024

Breast cancer in Switzerland: a comparison between organized-screening versus opportunistic-screening cantons.

Breast cancer in Switzerland: a comparison between organized-screening versus opportunistic-screening cantons.

Journal: ESMO open

Published: April 07, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026